This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,453.35, is for the delivery of Emtricitabine-Tenofovir 200-300mg medication in 30-count packages.
The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen is the prime contractor, and the contract supports the delivery of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/28/25, 10:56 AM